JRCT ID: jRCT1041200085
Registered date:25/12/2020
Analysis of Liposomal irinotecan's pharmacokinetics and side effects
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Pancreatic cancer |
Date of first enrollment | 25/12/2020 |
Target sample size | 15 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Comparison of drug concentration of Irinotecan and its metabolites by UGT1A1 gene polymorphism |
---|---|
Secondary Outcome | Secondary Outcome(s)Adverse events, Time to treatment failure, Effectiveness (Response rate, progression-free survival, Overall survival) |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Pancreatic cancer, underwent UGT1A1 polymorphism test |
Exclude criteria | Already used Onivyde(Liposomal irinotecan) |
Related Information
Primary Sponsor | ANDO Yuichi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Satoshi FURUNE |
Address | 65 Tsurumai-cho Showa-ku,Nagoya, Aichi Aichi Japan 466-0065 |
Telephone | +81-527442172 |
s-furune@med.nagoya-u.ac.jp | |
Affiliation | Nagoya University Hospital |
Scientific contact | |
Name | Yuichi ANDO |
Address | 65 Tsurumai-cho Showa-ku,Nagoya, Aichi Aichi Japan 466-0065 |
Telephone | +81-527442172 |
yando@med.nagoya-u.ac.jp | |
Affiliation | Nagoya University Hospital |